Law360, New York (July 10, 2012, 6:44 PM ET) -- The Federal Trade Commission is "nowhere near" running out of ways to challenge pay-for-delay deals as it continues to pursue both litigation over the allegedly anti-competitive patent settlements as well as legislative fixes, Chairman Jon Leibowitz told Law360.
Despite pursuing the settlements between brand drugmakers and generics companies for over a decade, the antitrust agency has had little luck persuading courts to block the agreements and repeated efforts to pass legislation banning the deals have not fared much better. But Leibowitz told Law360 on Monday that...
FTC Won't Abandon Pay-For-Delay Offensive, Chief Says
To view the full article, take a free trial now.
